Shorepoint Capital Partners’s CME Group CME Stock Holding History

Shorepoint Capital Partners’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$2.5M	Buy	+9,257	New	+$2.52M	0.5%	65

Other funds holding CME

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Shorepoint Capital Partners's CME Position: Q3 2025 in Review

Shorepoint Capital Partners opened a new position in CME Group (CME) in Q3 2025: 9,257 shares worth $2.5M. The stake represents 0.5% of the portfolio and ranks #65 among its holdings.

1,650 funds tracked by Wall St. Rank hold CME as of Q3 2025.

Shorepoint Capital Partners held 9,257 shares of CME Group worth $2.5M as of Q3 2025.
CME Group was a new Shorepoint Capital Partners position in Q3 2025.
CME Group made up 0.5% of Shorepoint Capital Partners's portfolio in Q3 2025, its #65 holding.
1,650 funds tracked by Wall St. Rank held CME Group as of Q3 2025.

Based on Shorepoint Capital Partners's 13F filing for Q3 2025, filed 3 Oct 2025.